Clonidine-Remifentanil. Effect of the Combination on Acute Pain and Respiration in Healthy Volunteers
Phase 1
Completed
- Conditions
- Acute PainRespirationSedation
- Interventions
- Drug: Remifentanil+clonidine
- Registration Number
- NCT00730054
- Lead Sponsor
- Oslo University Hospital
- Brief Summary
The hypothesis is that systemic remifentanil and Clonidine act in a synergistic manner to relief acute main in an experimental human pain model. Of interest is also the effect of the combination on respiration, sedation and cognitive behavior.
- Detailed Description
To examine the possible synergistic effects og systemic remifentanil and clonidine. Its effects on respiration, cognitive function and sedation.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 12
Inclusion Criteria
- Healthy volunteers
Exclusion Criteria
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description 1 Remifentanil+clonidine Clonidine 2 Remifentanil+clonidine Remifentanil 4 Remifentanil+clonidine Remifentanil+clonidine 3 Remifentanil+clonidine Placebo
- Primary Outcome Measures
Name Time Method Relief of pain(VAS reduction) Experimental
- Secondary Outcome Measures
Name Time Method Reduction in Minute ventilation Experimental Reduction in CO2 stimulated Minute Ventilation experimental Reduction in BIS score Experimental Performance on Stroop test Experimental
Trial Locations
- Locations (1)
Dep of Anesthesia and Intensive Care, Rikshospitalet-Radiumhospitalet Medical Center
🇳🇴Oslo, Norway